Serving leading biopharmaceutical companies globally:

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

LUCENTIS Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: LUCENTIS

Patents:	169
Applicants:	1
BLAs:	1
Suppliers: see list	1

Pharmacology for LUCENTIS

Mechanism of Action	Vascular Endothelial Growth Factor Receptor Inhibitors Vascular Endothelial Growth Factor-directed Antibody Interactions

US Patents for LUCENTIS

Subscribe to access the full database, or request a copy of the full page.
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	See Pricing	EYED PHARMA (Liege, BE)	2033-11-14	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	See Pricing	LegoChem Biosciences, Inc. (Daejeon, KR)	2034-05-28	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	See Pricing	Roche Diagnostics Operations, Inc. (Indianapolis, IN)	2028-07-23	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	See Pricing	Board of Trustees of Northern Illinois University (DeKalb, IL)	2033-08-16	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	See Pricing	NeuClone Biologics Pty Ltd (Eveleigh, NSW, AU)	2033-08-03	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	See Pricing	Avalanche Australia PTY Ltd. (Southbank Victoria, AU)	2032-05-15	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	See Pricing	Research Development Foundation (Carson City, NV)	2027-06-06	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for LUCENTIS

Subscribe to access the full database, or request a copy of the full page.
Country	Patent Number	Estimated Expiration
European Patent Office	3243530	See Pricing
Japan	2011507631	See Pricing
World Intellectual Property Organization (WIPO)	2008098216	See Pricing
Denmark	2320989	See Pricing
China	102333544	See Pricing
Singapore	186451	See Pricing
New Zealand	603185	See Pricing
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

Mallinckrodt

AstraZeneca

Moodys

Dow

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.